MCA logo



Advancements in COPD Management: Singapore’s HSA Approves Revefenacin (Yupelri®)

revefenacin (Yupelri)

Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory lung disease characterised by irreversible airflow limitation and associated with significant morbidity and mortality. In 2014, COPD was ranked the 10

Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

Popular Asian Noodle Products Recalled Due To Carcinogenic Chemical

The Malaysian Health Ministry has issued a voluntary recall for ‘Ah Lai White Curry Noodles’ and ‘Indomie: Special Chicken Flavour’ noodles from Indonesia after reports revealed the products contained ethylene oxide. The Taiwanese Health Department has also found ethylene oxide in the Indomie product. It has demanded a full recall.

Read More »